As Chief Data Officer for Odyssey Therapeutics, Dr. McDonald brings more than 30 years’ experience in the biopharmaceutical industry. Prior to Odyssey, Dr. McDonald served as executive director of machine-learning and physics-based simulation at Bristol Myers Squibb and Celgene. In previous roles at Celgene, Avila, and Pfizer, he held increasing roles of responsibility in computational chemistry, patent science, and chemical sample management. Dr. McDonald is also a co-author and inventor of more than 160 papers and patents. Dr. McDonald received his Ph.D. in biophysics from Roswell Park Memorial Institute and completed postdoctoral studies in computational chemistry at Carnegie Mellon University.